dc.contributor.author |
Varsha, K K |
|
dc.contributor.author |
Nampoothiri, K M |
|
dc.contributor.author |
Shilpa, G |
|
dc.contributor.author |
Priya, S |
|
dc.date.accessioned |
2023-01-26T06:27:04Z |
|
dc.date.available |
2023-01-26T06:27:04Z |
|
dc.date.issued |
2021-06 |
|
dc.identifier.citation |
Letters in Applied Microbiology;72(6):706-713 |
en_US |
dc.identifier.uri |
https://doi.org/10.1111/lam.13464 |
|
dc.identifier.uri |
http://localhost:8080/xmlui/handle/123456789/4204 |
|
dc.description.abstract |
A bioactive peptide of 8595 Da was purified from the cell free supernatant of
Lactococcus garvieae subsp. bovis BSN307T
. MALDI MS/MS peptide mapping
and the data base search displayed no significant similarity to any reported
antimicrobial peptide of LAB. This peptide at a dose concentration of
200 µg ml−1 inhibited the growth of both Gram-positive and Gram-negative
bacteria by 58–89% and a dose of 500 µg ml−1 scavenged 50% of DPPH-free
radicals generated. Interestingly, cytotoxicity assay demonstrated that
17 µg ml−1 of peptide selectively inhibited 50% proliferation of mammalian
cancer cell lines HeLa and MCF-7 whereas normal H9c2 cells remained
unaffected. Fluorescent microscopic analysis after DAPI nuclear staining of
HeLa cells showed characteristics of apoptosis and activation of caspase-3 was
ascertained by caspase-3 fluorescence assay. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Wiley |
en_US |
dc.subject |
antimicrobials |
en_US |
dc.subject |
cytotoxicity |
en_US |
dc.subject |
lactic acid bacteria |
en_US |
dc.subject |
peptides |
en_US |
dc.subject |
probiotics |
en_US |
dc.title |
Antimicrobial Activity and Cytotoxicity Trait of a Bioactive Peptide Purified from Lactococcus Garvieae Subsp. Bovis BSN307 T |
en_US |
dc.type |
Article |
en_US |